Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review.
about
Targeted Lung Cancer Treatments and Eye MetastasisComparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review.Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review.PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy.EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.
P2860
Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of the RECIST 1.0 a ...... a pooled analysis and review.
@en
Comparison of the RECIST 1.0 a ...... a pooled analysis and review.
@nl
type
label
Comparison of the RECIST 1.0 a ...... a pooled analysis and review.
@en
Comparison of the RECIST 1.0 a ...... a pooled analysis and review.
@nl
prefLabel
Comparison of the RECIST 1.0 a ...... a pooled analysis and review.
@en
Comparison of the RECIST 1.0 a ...... a pooled analysis and review.
@nl
P2860
P356
P1433
P1476
Comparison of the RECIST 1.0 a ...... a pooled analysis and review.
@en
P2093
Jung Han Kim
P2860
P304
13680-13687
P356
10.18632/ONCOTARGET.7322
P407
P5008
P577
2016-02-11T00:00:00Z
2016-03-22T00:00:00Z